BK

Binu Kozhimannil Mathew

Active Director Director DIN 10489586
DIN 10489586 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value •••• Premium profile

About Binu Kozhimannil Mathew

Data last updated:

Binu Kozhimannil Mathew is a Director at Grl Pharma Private Limited (since 2024). The company operates in Pharma. Grl Pharma Private Limited reported revenue of ₹2.09 Cr (FY 2025).

DIN 10489586
Primary Designation Director
Industry Pharma
First Appointment 03 Feb 2024
Oldest Company Age 3 yrs
Largest company Grl Pharma Private Limited · ₹2.09 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Grl Pharma Private Limited U46497KL2023PTC084158
Director03 Feb 20242023₹2.09 Cr (FY 2025)Active

Board colleagues of Binu Kozhimannil Mathew

Directorship timeline

Open interactive timeline →
Grl Pharma Private Limited
Premium access

Shareholding and investment profile for Binu Kozhimannil Mathew

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Binu Kozhimannil Mathew

Binu Kozhimannil Mathew currently holds 1 directorship: Grl Pharma Private Limited (Director, since 03 Feb 2024, revenue ₹2.09 Cr (FY 2025)).

Binu Kozhimannil Mathew was first appointed on 03 Feb 2024 as Director at Grl Pharma Private Limited.

The current boards of Binu Kozhimannil Mathew's companies include Chandrasekharan Hemalatha Anush (Grl Pharma Private Limited), Mangalam Krishnan Sachidanandan (Grl Pharma Private Limited), Mundangattil Rahul Raju (Grl Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available